Exenatide Circular RNA-Lipid Nanoparticle (Peg Bio)

N/A

Report date: 2026/04/07 20:00:20

Base Information

Drug NameExenatide Circular RNA-Lipid Nanoparticle (Peg Bio)
Drug Alias NameCR059CR-059
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Circular RNACell and gene therapy > Gene therapy > LNP
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPeg Bio Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPeg Bio Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A